[EU law on marketing authorization of medicines. History, current state of development and perspectives].
The article describes the development of EU policies and regulations on the marketing authorization of medicines. First, it describes the changing perspective of the EU towards the regulation of such authorizations. While its original focus was on the liberalization of national markets, it has today assumed overarching political responsibility for the development and marketing of medicines. Second, the article describes the current, rather fragmented regulatory system. Finally, political perspectives on the integration of markets for medicines are developed.
Juristische Facultät, Universität Tübingen, Wilhelmstrasse 7, Tübingen, BRD. nettesheim@jura.uni-tuebingen.de
Martin
M
Nettesheim
D003299:Cooperative Behavior; D017277:Drug Approval / Q000458:organization & administration*; D004345:Drug Industry / Q000458:organization & administration*; D005060:Europe; D005062:European Union / Q000458:organization & administration*; D007373:Interinstitutional Relations; D007880:Legislation, Drug; D040541:Marketing / Q000458:organization & administration*; D004364:Pharmaceutical Preparations
D004364:Pharmaceutical Preparations